Hidradenitis suppurativa Resources

Like many skin conditions commonly encountered in primary care (e.g. dermatitis, psoriasis and acne vulgaris), hidradenitis suppurativa (HS) can be both difficult to spell and pronounce. HS can also be difficult to identify, despite being an inflammatory skin condition that affects as many people as psoriasis (Penzer Hick, 2022). As a consequence, it can sometimes take several years for patients to get a diagnosis; approximately 35% of people with HS reported it taking three to 10 years to be diagnosed (Nicolle, 2022).

Hidradenitis suppurativa (HS) is a chronic long-term condition that occurs mostly in intertriginous areas of the skin. Unfortunately, HS is often not recognised and is poorly managed in clinical practice. Early detection and referral to an appropriate service such as dermatology is essential to reduce the long-term impact of the disease. Treatment is
multifactorial and includes management of associated comorbidities and lifestyle factors, such as obesity and smoking, medication, surgical intervention and managing depression and anxiety. This article explores the assessment and management options for general practice nurses (GPNs) to consider when presented with a patient with HS.

Dermatological conditions are notoriously difficult to spell! Psoriasis with its silent ‘P’ and eczema without an ‘X’. But how about hidradenitis suppurativa (HS)? Hard to spell, hard to pronounce but, more importantly, really hard to be a patient with the condition.